Sera Prognostics, Inc.
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26
Company newsroom
Sera Prognostics, Inc.
NASDAQ:SERA
2 releases
Sera Prognostics, Inc.
SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Company Drives Significant Increases in Test Volume and Ordering Providers with Florida Becoming Second Medicaid State Covering Test PreTRM® test…